Boston-based a2z Radiology raised $4.5M and earned FDA clearance for its Unified Triage AI solution for abdominal and pelvic CT scans.
Key Details
- 1a2z Radiology, founded in 2024, is developing AI tools for medical imaging interpretation.
- 2The company secured $4.5 million in seed funding from investors including SeaX and Khosla Ventures.
- 3Its Unified Triage system received FDA clearance and is designed as a multi-condition tool for abdomen-pelvis CT analysis.
- 4a2z claims its product is the first of its kind, focusing on broad multi-condition triage instead of single findings.
- 5The funds will be used to commercially deploy Unified Triage and develop further imaging AI products.
- 6Harvard biomedical informatics professor Pranav Rajpurkar co-founded the startup.
Why It Matters
Multi-condition AI tools could streamline radiology workflows, helping to detect a broader range of pathologies in a single scan and supporting radiologist efficiency. Regulatory milestones and investment indicate escalating momentum for generalist AI in medical imaging.
Source
Radiology Business
Related News
•AuntMinnie
AI Model Predicts Dosimetry for Lu-177 PSMA Therapy Using PET/CT
A machine learning PET/CT model shows promise for predicting radiation dose prior to Lu-177 PSMA therapy in prostate cancer patients.
•AuntMinnie
Human-AI Collaboration Achieves 99.2% Sensitivity for PE Detection in CTPA
A large study confirms that combining radiologists with FDA-cleared AI significantly improves pulmonary embolism detection on CTPA.
•Radiology Business
Radiologist-AI Collaboration Boosts Pulmonary Embolism Detection on CTPA
Combining AI with radiologists substantially improves detection of pulmonary embolism (PE) on CT pulmonary angiography (CTPA) scans, new research shows.